The Blood Microbiome and Health: Current Evidence, Controversies, and Challenges
International Journal of Molecular Sciences · 15.03.2023 · 24 (6) · 5633
DOI: 10.3390/ijms24065633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.03.2023. Verfasst von Hong Sheng Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Microbiota, Legionella. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blood is conventionally thought to be sterile. However, emerging evidence on the blood microbiome has started to challenge this notion. Recent reports have revealed the presence of genetic materials of microbes or pathogens in the blood circulation, leading to the conceptualization of a blood microbiome that is vital for physical wellbeing. Dysbiosis of the blood microbial profile has been implicated in a wide range of health conditions. Our review aims to consolidate recent findings about the blood microbiome in human health and to highlight the existing controversies, prospects, and challenges around this topic. Current evidence does not seem to support the presence of a core healthy blood microbiome. Common microbial taxa have been identified in some diseases, for instance, Legionella and Devosia in kidney impairment, Bacteroides in cirrhosis, Escherichia/Shigella and Staphylococcus in inflammatory diseases, and Janthinobacterium in mood disorders. While the presence of culturable blood microbes remains debatable, their genetic materials in the blood could potentially be exploited to improve precision medicine for cancers, pregnancy-related complications, and asthma by augmenting patient stratification. Key controversies in blood microbiome research are the susceptibility of low-biomass samples to exogenous contamination and undetermined microbial viability from NGS-based microbial profiling, however, ongoing initiatives are attempting to mitigate these issues. We also envisage future blood microbiome research to adopt more robust and standardized approaches, to delve into the origins of these multibiome genetic materials and to focus on host–microbe interactions through the elaboration of causative and mechanistic relationships with the aid of more accurate and powerful analytical tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore 308232, Singapore.
- Radiotherapy and Oncology Department, Hospital Sultan Ismail, Jalan Mutiara Emas Utama, Taman Mount Austin, Johor Bahru 81100, Malaysia.
- School of Biological Sciences, Nanyang Technological University Singapore, Singapore 637551, Singapore.
ORCID-Profile: Hong Sheng Cheng, Sunny Hei Wong, Nguan Soon Tan
Zitieren
APA
Cheng, H. S., Tan, S. P., Wong, D. M. K., Koo, W. L. Y., Wong, S. H., & Tan, N. S. (2023). The Blood Microbiome and Health: Current Evidence, Controversies, and Challenges. International Journal of Molecular Sciences, 24(6), 5633. https://doi.org/10.3390/ijms24065633
Vancouver
Cheng HS, Tan SP, Wong DMK, Koo WLY, Wong SH, Tan NS. The Blood Microbiome and Health: Current Evidence, Controversies, and Challenges. International Journal of Molecular Sciences. 2023;24(6):5633. doi:10.3390/ijms24065633
BibTeX
@article{Cheng2023,
author = {Cheng, Hong Sheng and Tan, Sin Pei and Wong, David Meng Kit and Koo, Wei Ling Yolanda and Wong, Sunny Hei and Tan, Nguan Soon},
title = {The Blood Microbiome and Health: Current Evidence, Controversies, and Challenges},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5633},
doi = {10.3390/ijms24065633}
}
EUVIMED